Literature DB >> 21087295

What is the right dose for children?

Massimo Cella1, Catherijne Knibbe, Meindert Danhof, Oscar Della Pasqua.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21087295      PMCID： PMC2950994          DOI： 10.1111/j.1365-2125.2009.03591.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  41 in total

1.  Relationship between clinical and biologic variables and chloramphenicol pharmacokinetic parameters in pediatric patients with sepsis.

Authors:  G Lugo Goytia; I Lares-Asseff; M G Pérez Guillé; A G Pérez; C L Mejía
Journal:  Ann Pharmacother       Date:  2000-03       Impact factor: 3.154

2.  Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children.

Authors:  S Conroy; I Choonara; P Impicciatore; A Mohn; H Arnell; A Rane; C Knoeppel; H Seyberth; C Pandolfini; M P Raffaelli; F Rocchi; M Bonati; G Jong; M de Hoog; J van den Anker
Journal:  BMJ       Date:  2000-01-08

3.  Pharmacokinetics of tobramycin in cystic fibrosis.

Authors:  H B Kelly; R Menendez; L Fan; S Murphy
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

Review 4.  What is the best size descriptor to use for pharmacokinetic studies in the obese?

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

5.  Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medication.

Authors:  R Riva; M Contin; F Albani; E Perucca; G Procaccianti; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

6.  Carbamazepine and its 10,11-epoxide in children and adults with epilepsy.

Authors:  S Pynnönen; M Sillanpää; H Frey; E Iisalo
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

Review 7.  Practice patterns of pediatric versus general emergency physicians for pain management of fractures in pediatric patients.

Authors:  Lynn Babcock Cimpello; Hnin Khine; Jeffrey R Avner
Journal:  Pediatr Emerg Care       Date:  2004-04       Impact factor: 1.454

8.  Chloramphenicol pharmacokinetics in the newborn.

Authors:  P Rajchgot; C Prober; S Soldin; C Golas; F Good; L Harding; S MacLeod
Journal:  Dev Pharmacol Ther       Date:  1983

Review 9.  Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Authors:  Gregory L Kearns; Susan M Abdel-Rahman; Sarah W Alander; Douglas L Blowey; J Steven Leeder; Ralph E Kauffman
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

Review 10.  Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.

Authors:  Gary Ginsberg; Dale Hattis; Abel Russ; Babasaheb Sonawane
Journal:  J Toxicol Environ Health A       Date:  2004-02-27
View more
  49 in total

1.  Testing new drugs in naked apes and getting the dose right in their young.

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

2.  Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.

Authors:  Massimo Cella; Catherijne Knibbe; Saskia N de Wildt; Joop Van Gerven; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

3.  Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.

Authors:  Wei Zhao; Valérie Biran; Evelyne Jacqz-Aigrain
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

4.  Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children.

Authors:  Chiara Piana; Wei Zhao; Kimberly Adkison; David Burger; Evelyne Jacqz-Aigrain; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

5.  Predicting pediatric age-matched weight and body mass index.

Authors:  Sherwin K B Sy; Eduardo Asin-Prieto; Hartmut Derendorf; Emil Samara
Journal:  AAPS J       Date:  2014-08-26       Impact factor: 4.009

6.  Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure.

Authors:  Faraz S Ahmad; Michael A Kallen; Karen E Schifferdecker; Kathleen L Carluzzo; Susan E Yount; Jill M Gelow; Peter A McCullough; Stephen E Kimmel; Elliot S Fisher; David Cella
Journal:  Circ Heart Fail       Date:  2019-06-05       Impact factor: 8.790

7.  Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.

Authors:  Roosmarijn F W De Cock; Karel Allegaert; Janneke M Brussee; Catherine M T Sherwin; Hussain Mulla; Matthijs de Hoog; Johannes N van den Anker; Meindert Danhof; Catherijne A J Knibbe
Journal:  Pharm Res       Date:  2014-05-02       Impact factor: 4.200

8.  Scaling adult doses of antifungal and antibacterial agents to children.

Authors:  Thomas H Dawson
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

9.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

10.  The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults.

Authors:  Chenguang Wang; Karel Allegaert; Mariska Y M Peeters; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.